Emanuele De Rinaldis

Vice President & Global Head, Target, Diseases & Systems Biology Sanofi

Emanuele de Rinaldis is the Global Head of Target, Diseases & Systems Biology at Sanofi, where he leads teams leveraging human genetics, clinical data, multi-omics, and functional genomics to establish causal disease biology and translate these insights into therapeutic targets, biomarkers, and patient-stratification strategies across discovery and clinical development.

He built and led global multidisciplinary organizations spanning functional genomics, multi-cellular disease models, disease profiling, computational biology, and data science to convert complex biological evidence into actionable therapeutic hypotheses and development strategies across Oncology, Immunology, and Neurology.

Extensive experience advancing programs from discovery into preclinical and clinical development, including target identification and validation, biomarker strategy, and patient stratification. Author of 75+ peer-reviewed publications, including Nature Genetics, Nature Communications, Blood, Immunity, and The Lancet.

Seminars

Wednesday 7th October 2026
Panel Discussion: Applying AI & Advanced Data Analytics to Transform Biomarker Discovery & Clinical Trial Strategy for Improved Precision Medicine Programs
9:00 am

Presentation Details to be Announced

Wednesday 7th October 2026
Accelerating Target Discovery & Precision Medicine Through AI-Enabled Integration of Human Genetics & Multimodal Data
8:10 am
  • Building FAIR, AI-enabled disease data ecosystems to accelerate translational discovery and cross-domain decision making
  • Combining human genetics, multimodal biology, and AI to identify and prioritize causal therapeutic targets
  • Resolving disease endotypes through multimodal data integration to enable patient stratification and precision medicine
Emanuele_De_Rinaldes[1]